These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3548072)

  • 1. [Results using Cavinton in various diseases of the central nervous system in children].
    Ignatowicz R; Michałowicz R; Kmieć T
    Wiad Lek; 1986 Aug; 39(16):1101-5. PubMed ID: 3548072
    [No Abstract]   [Full Text] [Related]  

  • 2. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G; Németh B
    Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of a cerebral oxygenator drug in chronic encephalopathies (apropos of the trial of vincamine)].
    Fossey F; Pasquier C
    Rev Neuropsychiatr Infant; 1972; 20(11):887-91. PubMed ID: 4650072
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic disorders of cerebral blood circulation: possibilities of the use of cavinton].
    Kamchatnov PR; Zaĭtsev KA; Chugunov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4 Suppl 2):52-6. PubMed ID: 20740716
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN; Eremeeva SV
    Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of corglycon and cavinton on the hemodynamics of patients with initial manifestations of insufficiency of cerebral circulation].
    Ishchenko MM; Nechaĭ EE
    Vrach Delo; 1988 May; (5):53-5. PubMed ID: 3420871
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 10. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM; Shprakh VV; Savkov VS
    Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prospects of using cavinton for treating Ménière's disease].
    Nikolaev MP; Konstantinova ZD; Mertsalova ON; Sheremet AS
    Vestn Otorinolaringol; 1980; (3):18-22. PubMed ID: 7385520
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disturbances of brain metabolism in blood circulation disorders and their correction with cavinton].
    Zhloba AA; Nikitina VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(4):67-9. PubMed ID: 16737165
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of cavinton in neuropaediatrics].
    Studenikin VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):63-4. PubMed ID: 15847328
    [No Abstract]   [Full Text] [Related]  

  • 15. Study on the vasodilator effects of ethyl apovincaminate in neurosurgical patients.
    Fényes G; Tarjányi J; Ladvánszky C
    Arzneimittelforschung; 1976; 26(10a):1956-62. PubMed ID: 1037223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiocirculographic study of the effect of ethyl apovincaminate on the cerebral circulation.
    Fényes S; Földes J
    Arzneimittelforschung; 1976; 26(10a):1963-4. PubMed ID: 798589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1338-42. PubMed ID: 4072532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
    Sapary L; Horvath B; Alexy T; Marton Z; Kesmarky G; Zsots M; Nagy F; Czopf I; Toth K
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):47-51. PubMed ID: 16841484
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trials of using Cavinton in the form of intravenous infusion in the treatment of macular degeneration].
    Gerkowicz K; Toczołowski J; Jedrzejewski D; Jankowska I; Szponar B
    Klin Oczna; 1987 Mar; 89(3):95-6. PubMed ID: 3309450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.